At Accelerated Medical Diagnostics, we fuse expertise in cancer biology and drug/device combinations to develop objective, reproducible tests that provide clinicians with predictive information to enhance patient care.
Our product, PlatinDx, is a diagnostic assay for predicting which patients will respond to platinum-based chemotherapy. This predictive technology does not require patient or tumor genotype information or culturing of tumor cells.
Paul Henderson, CEO, and UC Davis adjunct faculty of Hematology and Oncology in the School of Medicine, speaks to the gathered assembly of faculty, staff, students and community members about his research into which technologies will benefit cancer patients.
Accelerated Medical Diagnostics, Inc.
2121 Second St. #B101
Davis, CA 95618